Ani Pharmaceuticals, Inc.

Ani Pharmaceuticals, Inc. company information, Employees & Contact Information

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our U.S. manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

Company Details

Employees
601
Address
500 Alexander Park, Princeton,new Jersey 08540,united States
Phone
(218)634-3500
Email
a@agentfin.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Princeton, New Jersey
Looking for a particular Ani Pharmaceuticals, Inc. employee's phone or email?

Ani Pharmaceuticals, Inc. Questions

News

ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET - GlobeNewswire

ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET GlobeNewswire

ANI Pharmaceuticals (NASDAQ: ANIP) to release Q3 2025 results Nov. 7; call information - Stock Titan

ANI Pharmaceuticals (NASDAQ: ANIP) to release Q3 2025 results Nov. 7; call information Stock Titan

ANI Pharmaceuticals to Present at Upcoming Investor Conferences - Yahoo Finance

ANI Pharmaceuticals to Present at Upcoming Investor Conferences Yahoo Finance

ANI Pharmaceuticals: More Than Just A Generics Company (NASDAQ:ANIP) - Seeking Alpha

ANI Pharmaceuticals: More Than Just A Generics Company (NASDAQ:ANIP) Seeking Alpha

ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET - Yahoo Finance

ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ET Yahoo Finance

Back-to-Back Healthcare Conferences: ANI Pharmaceuticals Leadership to Present at Morgan Stanley, H.C. Wainwright - Stock Titan

Back-to-Back Healthcare Conferences: ANI Pharmaceuticals Leadership to Present at Morgan Stanley, H.C. Wainwright Stock Titan

ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME) - Yahoo Finance

ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME) Yahoo Finance

ANI Pharmaceuticals Sets Q2 2025 Earnings Call Date: Key Executive Team to Present Financial Results - Stock Titan

ANI Pharmaceuticals Sets Q2 2025 Earnings Call Date: Key Executive Team to Present Financial Results Stock Titan

ANI Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 7, 2025 - Quiver Quantitative

ANI Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 7, 2025 Quiver Quantitative

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ - GlobeNewswire

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ GlobeNewswire

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 - Yahoo Finance

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 Yahoo Finance

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets - GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe - GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label - GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label GlobeNewswire

ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance - GlobeNewswire

ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance GlobeNewswire

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance - GlobeNewswire

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance GlobeNewswire

ANI Pharmaceuticals to Present at H.C. Wainwright and Morgan Stanley Investor Conferences - Quiver Quantitative

ANI Pharmaceuticals to Present at H.C. Wainwright and Morgan Stanley Investor Conferences Quiver Quantitative

ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner - Yahoo Finance

ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner Yahoo Finance

ANI Pharmaceuticals, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025 - Quiver Quantitative

ANI Pharmaceuticals, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025 Quiver Quantitative

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution - Yahoo Finance

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution Yahoo Finance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP - Yahoo Finance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP Yahoo Finance

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance - GlobeNewswire

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP - Yahoo Finance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP Yahoo Finance

ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET - Business Wire

ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET Business Wire

ANIP - Ani Pharmaceutic Latest Stock News & Market Updates - Stock Titan

ANIP - Ani Pharmaceutic Latest Stock News & Market Updates Stock Titan

ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients - Veeva

ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients Veeva

ANI Pharmaceuticals CEO Joins Elite Therapeutics Forum: Key Investor Meetings Ahead - Stock Titan

ANI Pharmaceuticals CEO Joins Elite Therapeutics Forum: Key Investor Meetings Ahead Stock Titan

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences - GlobeNewswire

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences GlobeNewswire

ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET - Stock Titan

ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET Stock Titan

ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares - Yahoo Finance

ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares Yahoo Finance

ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP - Business Wire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP Business Wire

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences - GlobeNewswire

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences GlobeNewswire

ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET - FinancialContent

ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET FinancialContent

Appco Pharma LLC Issues Voluntary Nationwide Recall of Ranitidine Hydrochloride Capsules 150 mg and 300 mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) - fda.gov

Appco Pharma LLC Issues Voluntary Nationwide Recall of Ranitidine Hydrochloride Capsules 150 mg and 300 mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) fda.gov

ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference - FinancialContent

ANI Pharmaceuticals to Present at the H.C. Wainwright Bioconnect Virtual Conference FinancialContent

ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 - FinancialContent

ANI Pharmaceuticals to Present at the Piper Sandler 33rd Annual Healthcare Conference 2021 FinancialContent

Once Discontinued Antiarrhythmic Agent Will Soon Be Available Again - Medical Professionals Reference

Once Discontinued Antiarrhythmic Agent Will Soon Be Available Again Medical Professionals Reference

Top Ani Pharmaceuticals, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant